Bulletin
Investor Alert

Syneos Health Inc. Cl A

NAS: SYNH

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jan 24, 2020, 4:11 p.m.

/zigman2/quotes/207981284/composite

$

62.67

Change

0.00 0.00%

Volume

Volume 7,857

Quotes are delayed by 20 min

/zigman2/quotes/207981284/composite

Previous close

$ 64.69

$ 62.67

Change

-2.02 -3.12%

Day low

Day high

$62.51

$65.17

Open

52 week low

52 week high

$36.72

$65.17

Open

Insider Actions for Syneos Health Inc. Cl A

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
01/15/2020 Alistair John Macdonald
Chief Executive Officer; Director
48,770   Award at $0 per share. 0
01/15/2020 Jason Michael Meggs
Chief Financial Officer
13,803   Award at $0 per share. 0
01/15/2020 Michelle Keefe
Pres., Commercial Solutions
11,862   Award at $0 per share. 0
01/15/2020 Jonathan Olefson
General Counsel & Corp Secty
6,692   Award at $0 per share. 0
01/15/2020 Paul D. Colvin
Pres., Clinical Solutions
11,862   Award at $0 per share. 0
01/08/2020 Alistair John Macdonald
Chief Executive Officer; Director
10,155   Derivative/Non-derivative trans. at $59.96 per share. 608,893
01/08/2020 Jason Michael Meggs
Chief Financial Officer
1,732   Derivative/Non-derivative trans. at $59.96 per share. 103,850
01/08/2020 Michelle Keefe
Pres., Commercial Solutions
1,559   Derivative/Non-derivative trans. at $59.96 per share. 93,477
01/08/2020 Jonathan Olefson
General Counsel & Corp Secty
1,095   Derivative/Non-derivative trans. at $59.96 per share. 65,656
01/08/2020 Paul D. Colvin
Pres., Clinical Solutions
1,404   Derivative/Non-derivative trans. at $59.96 per share. 84,183
01/08/2020 Robert Alan Parks
EVP, Chief Accounting Officer
679   Derivative/Non-derivative trans. at $59.96 per share. 40,712
01/02/2020 Paul D. Colvin
Pres., Clinical Solutions
249   Derivative/Non-derivative trans. at $59.51 per share. 14,817
12/03/2019 Robert Alan Parks
EVP, Chief Accounting Officer
660   Derivative/Non-derivative trans. at $54.4 per share. 35,904
12/01/2019 Michelle Keefe
Pres., Commercial Solutions
364   Derivative/Non-derivative trans. at $54.89 per share. 19,979
11/13/2019 Jonathan Olefson
General Counsel & Corp Secty
1,047   Derivative/Non-derivative trans. at $49.47 per share. 51,795
11/12/2019 Bernadette M. Connaughton
Director
1,909   Award at $49.48 per share. 94,457
11/01/2019 Jason Michael Meggs
Chief Financial Officer
23   Derivative/Non-derivative trans. at $50.5 per share. 1,161
08/01/2019 Alistair John Macdonald
Chief Executive Officer; Director
4,178   Derivative/Non-derivative trans. at $48.99 per share. 204,680
07/29/2019 Jason Michael Meggs
Chief Financial Officer
157   Derivative/Non-derivative trans. at $49.33 per share. 7,744

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
6 Purchases
11 Sales
94,898
18,967
Last 6 months
6 Purchases
13 Sales
94,898
23,302
Last 12 months
17 Purchases
22 Sales
146,836
5,564,332

Officers and Executives

Mr. Alistair John Macdonald
Chief Executive Officer & Director
Mr. Jason Michael Meggs
Chief Financial Officer & Executive Vice President
Mr. Purvesh Patel
Chief Administrative Officer & Executive VP
Ms. Michelle Keefe
President-Commercial Solutions
Mr. Paul D. Colvin
President-Clinical Solutions
Mr. Neil Ferguson
Chief Business Officer
Mr. Mark Dmytruk
Executive VP-Corporate Strategy & Development
Ms. Kristen Spensieri
Head- Global Communications & Marketing
Mr. Robert Alan Parks
Chief Accounting Officer & Executive VP
Mr. Ronnie Speight
Vice President-Investor Relations
Ms. Lisa van Capelle
Chief Human Resources Officer
Mr. Jonathan Olefson
Secretary & General Counsel
Mr. John M. Dineen
Chairman
Mr. Kenneth F. Meyers
Independent Director
Mr. Todd M. Abbrecht
Independent Director
Mr. William E. Klitgaard
Independent Director
Mr. John L. Maldonado
Independent Director
Mr. Joshua M. Nelson
Independent Director
Ms. Linda A. Harty
Independent Director
Mr. Matthew E. Monaghan
Independent Director
Mr. Thomas Alexander Allen
Independent Director
Ms. Bernadette M. Connaughton
Independent Director
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.